--- title: "Scheduled Monitoring | Kisqali®" description: "Explore Kisqali monitoring in ABC: requires regular monitoring through cycle 6, with additional assessments as clinically indicated." canonical_url: "https://www.kisqali.com/advanced-breast-cancer/monitoring-and-dosing/scheduled-monitoring" meta: "og:description": "Explore Kisqali monitoring in ABC: requires regular monitoring through cycle 6, with additional assessments as clinically indicated." "og:title": "Scheduled Monitoring" --- ## **Scheduled monitoring** ### **KISQALI monitoring requirements. **⁽¹⁾ **KISQALI monitoring requirements have been simplified and there is no scheduled monitoring beyond cycle 6, unless clinically indicated. **⁽¹⁾ ![Table displaying KISQALI monitoring schedule from baseline through cycle 6, showing when to perform CBC and LFT, electrolytes, and ECG tests. All three tests are required at baseline. CBC/LFT and ECG are repeated on Cycle 1 Day 14. Electrolytes and CBC/LFT are tested on Cycle 2 Day 1. From cycles 3 to 6, Day 1, CBC/LFT and electrolytes are required, while ECG is not.](https://www.kisqali.com/img/advanced-breast-cancer/mobile/kisqali-monitoring-schedule-tests-cycles.svg) \* If grade ≥2 abnormalities are observed, more frequent monitoring is recommended. ⁽¹⁾ ^† Correct electrolyte abnormalities prior to and during treatment. ⁽¹⁾ ^‡ Only initiate KISQALI in patients with QTcF <450 ms. In case of QTcF prolongation during therapy, more frequent assessments are recommended. ⁽¹⁾ ## Sitemap See the full [sitemap](/sitemap.md) for all pages.